Re­pair, Genevant ink deal worth up to $107M; 858 Ther­a­peu­tics rais­es $50M

Plus, news about Enan­ta, In­ven­ti­va, Eradi­vir, No­vo Nordisk, Evotec, Lund­beck, Iambic Ther­a­peu­tics and Wave Life Sci­ences:

Genevant Sci­ences, Re­pair Biotech­nolo­gies team up: The biotechs will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER